Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus Erythematosus

A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE Participants

NCT06625671 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Phase I Study of Immune Ablation and CD34+ Peripheral Blood Stem Cell Support in Patients With Systemic Lupus Erythematosus

NCT00017641 ·Status: UNKNOWN ·Phase: PHASE1

Low-dose IL-2( Interleukin-2) Treatment in SLE

NCT02084238 ·Status: COMPLETED ·Phase: NA

A Research Study to Assess if CC-930 is Safe in Treating Subjects With Discoid Lupus Erythematosus

NCT01466725 ·Status: TERMINATED ·Phase: PHASE2

Epidemiologic Study of Reproductive Outcome in Women With Systemic Lupus Erythematosus

NCT00004663 ·Status: COMPLETED

Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus

NCT01262365 ·Status: COMPLETED ·Phase: PHASE3

Treatment and Clinical Outcomes Among SLE Patients in Pregnancy

NCT04976465 ·Status: RECRUITING ·Phase: PHASE1

The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD

NCT05440422 ·Status: RECRUITING ·Phase: PHASE2

Efficacy of Faslodex in Treatment of SLE Clinical, Serologic, and Molecular Studies

NCT00417430 ·Status: COMPLETED ·Phase: PHASE2

Open Label Extension Study of Epratuzumab in Subjects With Systemic Lupus Erythematosus

NCT01408576 ·Status: COMPLETED ·Phase: PHASE3

NK010 or NK042 in Combination With Rituximab for Refractory Systemic Lupus Erythematosus/Lupus Nephritis

NCT06676631 ·Status: RECRUITING ·Phase: PHASE1

Study to Compare Properties of Epratuzumab When Given as an Injection Under the Skin or Directly Into the Blood

NCT02306629 ·Status: COMPLETED ·Phase: PHASE1

A Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321

NCT01305746 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability, and Pharmacokinetics of Single Doses of HC022 in Healthy Subjects.

NCT06657703 ·Status: RECRUITING ·Phase: PHASE1

Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies

NCT03453619 ·Status: COMPLETED ·Phase: PHASE2

A Study of a Single Ascending Dose Study of DS-7011a in Healthy Subjects

NCT05203692 ·Status: COMPLETED ·Phase: PHASE1

Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE)

NCT01261793 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Diseases

NCT06647069 ·Status: RECRUITING ·Phase: PHASE1

A Study of LY3361237 in Participants With Systemic Lupus Erythematosus

NCT03933943 ·Status: COMPLETED ·Phase: PHASE1

Autologous Stem Cell Transplantation for Refractory Systemic Lupus Erythematosus (ASSIST)

NCT00750971 ·Status: UNKNOWN ·Phase: PHASE2

GL701 (Prestara™) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids

NCT00082511 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

NCT04294667 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

NCT02446899 ·Status: COMPLETED ·Phase: PHASE3

Anti-infection of Low-does IL-2 in SLE

NCT02932137 ·Status: COMPLETED ·Phase: NA

A Phase II Clinical Study on the Efficacy and Safety of SHR-2173 Injection in the Treatment of Patients With Active Lupus Nephritis

NCT07229742 ·Status: RECRUITING ·Phase: PHASE2